{"id":"https://openalex.org/W189922895","doi":null,"title":"Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications.","display_name":"Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications.","publication_year":2000,"publication_date":"2000-04-01","ids":{"openalex":"https://openalex.org/W189922895","mag":"189922895","pmid":"https://pubmed.ncbi.nlm.nih.gov/10762139"},"language":"en","primary_location":{"id":"pmid:10762139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10762139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of neurology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110587831","display_name":"Thomas N. Chase","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T N Chase","raw_affiliation_strings":["Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110207419","display_name":"Justin D. Oh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J D Oh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.776,"has_fulltext":false,"cited_by_count":164,"citation_normalized_percentile":{"value":0.97918883,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"47","issue":"4 Suppl 1","first_page":"S122","last_page":"9; discussion S129"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.03440000116825104,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9879999756813049},{"id":"https://openalex.org/keywords/parkinsonian-signs","display_name":"parkinsonian signs","score":0.7919999957084656},{"id":"https://openalex.org/keywords/motor-complications","display_name":"motor complications","score":0.828000009059906},{"id":"https://openalex.org/keywords/levodopa-induced-dyskinesia","display_name":"levodopa-induced dyskinesia","score":0.9279999732971191},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8320000171661377},{"id":"https://openalex.org/keywords/nigrostriatal-dopamine-system","display_name":"nigrostriatal dopamine system","score":0.8029999732971191},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8479999899864197},{"id":"https://openalex.org/keywords/receptor-phosphorylation","display_name":"receptor phosphorylation","score":0.7549999952316284},{"id":"https://openalex.org/keywords/glutamatergic-synaptic-input","display_name":"glutamatergic synaptic input","score":0.7699999809265137},{"id":"https://openalex.org/keywords/signal-transduction","display_name":"signal transduction","score":0.8339999914169312},{"id":"https://openalex.org/keywords/striatal-output","display_name":"striatal output","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.7048569917678833},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.6838101148605347},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.5933605432510376},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.5552797913551331},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.5028960108757019},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4984440803527832},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.4971051514148712},{"id":"https://openalex.org/C2776355744","wikidata":"https://www.wikidata.org/wiki/Q4318555","display_name":"Nigrostriatal pathway","level":5,"score":0.482481986284256},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.4392469525337219},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.4215925335884094},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4189044237136841},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.3562535047531128},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32550299167633057},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.2751447558403015},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2747153043746948},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24880415201187134},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.10579696297645569}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009046","descriptor_name":"Motor Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009046","descriptor_name":"Motor Neurons","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D015259","descriptor_name":"Dopamine Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10762139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10762139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of neurology","raw_type":"Journal Article"},{"id":"mag:189922895","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10762139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1996046462","https://openalex.org/W2076847033","https://openalex.org/W1971301285","https://openalex.org/W2026105446","https://openalex.org/W2413928703","https://openalex.org/W1893069857","https://openalex.org/W2055347728","https://openalex.org/W1967015115","https://openalex.org/W1992428237","https://openalex.org/W2010873975"],"abstract_inverted_index":{"Recent":[0],"studies":[1],"suggest":[2],"that":[3,66,115,181,217],"motor":[4,61,126,225],"dysfunction":[5,127],"associated":[6],"with":[7,51,82],"the":[8,20,29,34,56,59,91,98,113,123,146,171,182,219],"chronic":[9],"nonphysiologic":[10],"stimulation":[11,184],"of":[12,22,28,38,55,58,117,125,149,158,185,198,221],"dopaminergic":[13,186],"receptors":[14,69,120,187,200],"on":[15],"striatal":[16,118,193,212],"spiny":[17],"neurons":[18],"alters":[19],"sensitivity":[21,204],"nearby":[23],"glutamatergic":[24,207],"receptors,":[25,142],"especially":[26],"those":[27],"N-methyl-D-aspartate":[30],"(NMDA)":[31],"subtype.":[32],"Lesioning":[33],"nigrostriatal":[35,159],"dopamine":[36],"system":[37,160],"rats":[39],"or":[40,48,93,103],"nonhuman":[41],"primates":[42],"induces":[43],"parkinsonian":[44,71,222],"signs;":[45],"subsequent":[46],"once-":[47],"twice-daily":[49],"treatment":[50],"levodopa":[52],"produces":[53],"many":[54],"features":[57],"human":[60],"complication":[62],"syndrome.":[63],"Some":[64],"drugs":[65],"block":[67],"NMDA":[68,86,119,141,199],"palliate":[70],"signs":[72,223],"in":[73,80,128,145,174,192,215],"these":[74],"animal":[75],"models,":[76],"as":[77,79,135,155,162,164],"well":[78,163],"patients":[81],"Parkinson's":[83,129],"disease.":[84,130],"Certain":[85],"receptor":[87],"antagonists":[88],"injected":[89],"into":[90],"striatum":[92],"given":[94],"systemically":[95],"also":[96],"have":[97],"ability":[99],"to":[100,105,122,205],"act":[101],"palliatively":[102],"prophylactically":[104],"alleviate":[106],"levodopa-induced":[107],"response":[108,165],"alterations.":[109],"These":[110],"observations":[111],"support":[112],"view":[114],"sensitization":[116],"contributes":[121],"pathogenesis":[124],"Since":[131],"protein":[132],"phosphorylation":[133,147,197],"serves":[134],"an":[136],"important":[137],"regulatory":[138],"mechanism":[139],"for":[140,170],"differential":[143],"increases":[144],"state":[148],"tyrosine":[150],"and":[151,201,224],"serine":[152],"residues,":[153],"observed":[154],"a":[156,210],"result":[157],"destruction":[161],"alteration":[166],"induction,":[167],"could":[168],"account":[169],"apparent":[172],"augmentation":[173],"synaptic":[175],"efficacy.":[176],"Current":[177],"evidence":[178],"thus":[179,202],"suggests":[180],"intermittent":[183],"activates":[188],"signal":[189],"transduction":[190],"pathways":[191],"neurons,":[194],"which":[195],"augment":[196],"their":[203],"cortical":[206],"input.":[208],"As":[209],"result,":[211],"output":[213],"changes":[214],"ways":[216],"favor":[218],"appearance":[220],"complications.":[226]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}